BDX vs CROX · P/E 34, rev $21.84B vs rev $4.10B
Becton Dickinson and Company (BDX) versus Crocs Inc (CROX) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Crocs Inc (CROX) is a footwear & accessories company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported CROX revenue for 2024-12-31 was $4.10B. Net income was $950.1M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. CROX currently screens at market cap $5.93B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CROX currently screens at market cap $5.93B.
Not investment advice. Open the BDX and CROX stock pages for the full models.
Not investment advice.